Tibet Weixinkang Medicine Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 667.92 million compared to CNY 499.76 million a year ago. Revenue was CNY 668.04 million compared to CNY 499.91 million a year ago.

Net income was CNY 102.97 million compared to CNY 53.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.24 compared to CNY 0.13 a year ago. Diluted earnings per share from continuing operations was CNY 0.24 compared to CNY 0.13 a year ago.